title: Influence of peripheral arterial occlusive disease on muscular metabolism. Part 1: Changes in lactate, ammonia, and hypoxanthine concentration in femoral blood.
abstract: The concentrations of lactate, ammonia and hypoxanthine were determined in blood from the femoral artery, femoral vein and cubital vein under resting conditions in 23 patients with stage II, 10 patients and 20 diabetics with stage IV peripheral arterial occlusive disease (PAOD) and in 19 healthy subjects. The metabolite concentrations were also measured immediately and 20 min after calf exercise in the patients with stage II PAOD and in the controls. At rest, there was a negative arteriovenous difference in femoral lactate level and a positive arteriovenous difference in the ammonia level in all groups. After exercise to the claudication limit, the femoral venous concentration and arteriovenous difference for lactate increased in the patient group significantly higher than in the controls, who were exercised three times as heavily. Furthermore, there was a significant rise in femoral venous ammonia concentration with inversion of the arteriovenous difference into the negative range and an increase in femoral venous hypoxanthine concentration only in the patients with PAOD and not in the controls. A significant correlation was found between the exercise-induced increases in lactate and ammonia. The results indicate activation of the purine nucleotide cycle in the muscles of limbs with impaired circulation, even for a short duration of load. This can be explained by activation of the AMP-deaminase in type I and type IIa muscle fibres by anoxaemia. The purine nucleotide cycle has an emergency metabolic function in ischaemia to maintain muscle contractility. Ammonia determination in femoral blood permits, in association with lactate and hypoxanthine determination, a precise quantitative assessment of the metabolic effects of PAOD.(ABSTRACT TRUNCATED AT 250 WORDS)
authors.affiliation: Medizinische Abteilung des St. Josefskrankenhauses Heidelberg.
authors.forename: W
authors.initials: W
authors.lastname: Rexroth
authors.forename: W
authors.initials: W
authors.lastname: Hageloch
authors.forename: F
authors.initials: F
authors.lastname: Isgro
authors.forename: T
authors.initials: T
authors.lastname: Koeth
authors.forename: G
authors.initials: G
authors.lastname: Manzl
authors.forename: H
authors.initials: H
authors.lastname: Weicker
mesh_terms: D000368:Aged; D000641:Ammonia / Q000097:blood*; D001157:Arterial Occlusive Diseases / Q000097:blood*; D003925:Diabetic Angiopathies / Q000097:blood; D005260:Female; D006801:Humans; D019271:Hypoxanthine; D007042:Hypoxanthines / Q000097:blood*; D007511:Ischemia / Q000097:blood; D007773:Lactates / Q000097:blood*; D019344:Lactic Acid; D007866:Leg / Q000098:blood supply; D008297:Male; D008875:Middle Aged; D009132:Muscles / Q000378:metabolism*
chemical_list: D007042:Hypoxanthines; D007773:Lactates; D019271:Hypoxanthine; D019344:Lactic Acid; D000641:Ammonia